Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Green Thumb Industries

Market Cap: CA$1.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$1.0b

Operates as a cannabis retailer.

Curaleaf Holdings

Market Cap: CA$953.0m

Produces and distributes cannabis products in the United States and internationally.

Cresco Labs

Market Cap: CA$404.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Aurora Cannabis

Market Cap: CA$337.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Bright Minds Biosciences

Market Cap: CA$334.4m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Verano Holdings

Market Cap: CA$315.9m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Canopy Growth

Market Cap: CA$272.1m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

High Tide

Market Cap: CA$263.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Spectral Medical

Market Cap: CA$228.1m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

NervGen Pharma

Market Cap: CA$209.4m

Engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.

Organigram Global

Market Cap: CA$202.0m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Eupraxia Pharmaceuticals

Market Cap: CA$189.3m

A clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

Theratechnologies

Market Cap: CA$171.7m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

TerrAscend

Market Cap: CA$131.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cardiol Therapeutics

Market Cap: CA$122.3m

A clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Satellos Bioscience

Market Cap: CA$114.4m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Planet 13 Holdings

Market Cap: CA$102.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Microbix Biosystems

Market Cap: CA$100.5m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Simply Better Brands

Market Cap: CA$87.9m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Medexus Pharmaceuticals

Market Cap: CA$83.9m

Operates as a pharmaceutical company in Canada and the United States.

Medicenna Therapeutics

Market Cap: CA$81.3m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Sernova Biotherapeutics

Market Cap: CA$72.3m

Operates as a clinical-stage biotechnology company in Canada.

Oncolytics Biotech

Market Cap: CA$68.4m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Covalon Technologies

Market Cap: CA$62.0m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

ZYUS Life Sciences

Market Cap: CA$58.7m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally.

NurExone Biologic

Market Cap: CA$52.3m

Operates as a pharmaceutical technology company.

Decibel Cannabis

Market Cap: CA$37.5m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Vext Science

Market Cap: CA$32.2m

Through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States.

Ayr Wellness

Market Cap: CA$26.9m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

Rubicon Organics

Market Cap: CA$26.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada.

Rakovina Therapeutics

Market Cap: CA$7.0m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Delivra Health Brands

Market Cap: CA$5.0m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.